1. Home
  2. NIU vs PBYI Comparison

NIU vs PBYI Comparison

Compare NIU & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Niu Technologies

NIU

Niu Technologies

HOLD

Current Price

$3.11

Market Cap

275.6M

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$6.39

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIU
PBYI
Founded
2014
2010
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.6M
263.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
NIU
PBYI
Price
$3.11
$6.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
681.2K
368.1K
Earning Date
11-17-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.87
EPS
N/A
0.74
Revenue
$625,182,280.00
$211,995,000.00
Revenue This Year
$42.51
N/A
Revenue Next Year
$23.71
N/A
P/E Ratio
N/A
$8.56
Revenue Growth
50.99
N/A
52 Week Low
$1.75
$2.58
52 Week High
$5.67
$6.48

Technical Indicators

Market Signals
Indicator
NIU
PBYI
Relative Strength Index (RSI) 43.18 64.96
Support Level $3.12 $6.05
Resistance Level $3.30 $6.29
Average True Range (ATR) 0.15 0.23
MACD 0.01 0.02
Stochastic Oscillator 20.45 86.12

Price Performance

Historical Comparison
NIU
PBYI

About NIU Niu Technologies

Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: